 Phosphodiesterase 3 Inhibitors
"Phosphodiesterase 3 Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that specifically inhibit PHOSPHODIESTERASE 3.
| Descriptor ID |
D058987
|
| MeSH Number(s) |
D27.505.519.389.735.249
|
| Concept/Terms |
Phosphodiesterase 3 Inhibitors- Phosphodiesterase 3 Inhibitors
- Inhibitors, Phosphodiesterase 3
- Phosphodiesterase Type 3 Inhibitors
- PDE-3 Inhibitors
- Inhibitors, PDE-3
- PDE 3 Inhibitors
- PDE3 Inhibitors
- Inhibitors, PDE3
|
Below are MeSH descriptors whose meaning is more general than "Phosphodiesterase 3 Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Phosphodiesterase 3 Inhibitors".
This graph shows the total number of publications written about "Phosphodiesterase 3 Inhibitors" by people in this website by year, and whether "Phosphodiesterase 3 Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 | | 2014 | 1 | 0 | 1 | | 2016 | 1 | 0 | 1 | | 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Phosphodiesterase 3 Inhibitors" by people in Profiles.
-
Mizuno T, Gist KM, Gao Z, Wempe MF, Alten J, Cooper DS, Goldstein SL, Vinks AA. Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery. Clin Pharmacokinet. 2019 06; 58(6):793-803.
-
Sucharov CC, Nakano SJ, Slavov D, Schwisow JA, Rodriguez E, Nunley K, Medway A, Stafford N, Nelson P, McKinsey TA, Movsesian M, Minobe W, Carroll IA, Taylor MRG, Bristow MR. A PDE3A Promoter Polymorphism Regulates cAMP-Induced Transcriptional Activity in Failing Human Myocardium. J Am Coll Cardiol. 2019 03 19; 73(10):1173-1184.
-
Nakano SJ, Nelson P, Sucharov CC, Miyamoto SD. Myocardial Response to Milrinone in Single Right Ventricle Heart Disease. J Pediatr. 2016 07; 174:199-203.e5.
-
Nakano SJ, Miyamoto SD, Movsesian M, Nelson P, Stauffer BL, Sucharov CC. Age-related differences in phosphodiesterase activity and effects of chronic phosphodiesterase inhibition in idiopathic dilated cardiomyopathy. Circ Heart Fail. 2015 Jan; 8(1):57-63.
-
Reusch JE. Beyond phosphorylation: nuclear export in vascular remodeling. Arterioscler Thromb Vasc Biol. 2011 Sep; 31(9):1955-6.
-
Lewis RJ, Connor JT, Teerlink JR, Murphy JR, Cooper LT, Hiatt WR, Brass EP. Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. Trials. 2011 May 25; 12:134.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|